1. Home
  2. FVRR vs VNDA Comparison

FVRR vs VNDA Comparison

Compare FVRR & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

HOLD

Current Price

$10.85

Market Cap

372.4M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.21

Market Cap

411.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVRR
VNDA
Founded
2010
2002
Country
Israel
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.4M
411.3M
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
FVRR
VNDA
Price
$10.85
$6.21
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$18.43
$14.90
AVG Volume (30 Days)
877.5K
1.1M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$216,105,000.00
Revenue This Year
N/A
$21.35
Revenue Next Year
$1.83
$37.40
P/E Ratio
$22.05
N/A
Revenue Growth
N/A
8.72
52 Week Low
$9.67
$4.14
52 Week High
$34.13
$9.91

Technical Indicators

Market Signals
Indicator
FVRR
VNDA
Relative Strength Index (RSI) 49.49 38.23
Support Level $9.97 $5.73
Resistance Level $11.33 $7.76
Average True Range (ATR) 0.52 0.31
MACD -0.06 -0.04
Stochastic Oscillator 32.46 12.18

Price Performance

Historical Comparison
FVRR
VNDA

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: